Media - Abzena

Events

BioProcess International East

9 September 2019

BPI attracts the brightest minds in bioprocessing to deliver you the cutting-edge science you need to accelerate[...] Read more

BIO International 2019

3 June 2019

Interested in accelerating your development timeline? Meet Abzena at BIO International Booth 3815. The BIO International[...] Read more

References

Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have utilized[...] Read more

News

Abzena expands leadership team with Andrew Kraus as Chief Technology Officer and Philip Payne as Chief Commercial Officer

San Diego, USA , 21 June 2019 – Abzena, the leading global biologics and ADC target partner research organization,[...] Read more

Abzena announces 14-month cell line to phase 1 GMP service and appointment of Shahram Katousian as Head of biologics manufacturing

San Diego, USA, 3 June 2019 – Abzena, the leading biotherapeutics target to GMP partner research organization (PRO)[...] Read more

Posts

We’re changing the way we brand our businesses

To provide our Partners with a single identity for the services and technologies offered across Antitope, PacificGMP,[...] Read more

Interested in our services? Get In Touch